299 results found.
                    
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
2018 Year in Review: Revenue Projections and Technology Trends
By Mike Evers In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies, shown here in Exhibit 1. Sales for these 25 companies account for approximately 80% of the worldwide orthopaedic market. We p...
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
Orthofix Reports 3Q18 Revenue of $111.7MM, +6.1% vs. 3Q17
Orthofix performance driven by bone growth and trauma products with 3Q18 revenue of US $111.7MM, +6.1% vs. 3Q17.
Spine Company M&A Picks Up in 3Q18
By Rob Meyer and Julie A. Vetalice Eight—yes, eight—spine acquisitions were announced in the four weeks since we published our analysis, “
Globus Medical Acquires Nemaris, Surgimap Software
Globus Medical is acquiring Nemaris, developer of Surgimap® software used to preoperatively plan spine surgery...
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
Spine Merger & Acquisition Activity Going Strong
By Julie A. Vetalice Updated September 2018 to include additional transactions from 3Q18. Throughout 2017 and thus far in 2018, players of all sizes in the spine segment have taken a variety of steps to fill portfolio gaps, bolster growth and remain competitive. ...
Spine Market Growth Expected to Remain at 2%
By Carolyn LaWell Spine accounts for 18% of the orthopaedic industry’s overall revenue. In 2017, estimated sales of spine products (excluding biologics) exceeded $9 billion worldwide, an increase of 2.2% or $197 million vs. 2016, according to our estimates published in
Orthofix Reports 2Q18 Revenue
Orthofix posted 2Q18 revenue of US $111.5MM, +2.4% vs. 2Q17, with 1H18 revenue of $220.3MM, +4.1% vs. 1H17.
Orthofix Reorganizes Business Units
Orthofix realigned its four strategic business units into Global Orthofix Extremities and Global Orthofix Spine
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
Trauma Market Attracts New Players
By Carolyn LaWell Trauma remains one of the more attractive markets for orthopaedic device companies due to demographics, ripeness for innovation and an increased focus on lower extremities care, to name just three factors. These strengths have led companies of all sizes—establish...
Orthofix Posts 1Q18 Revenue Growth of 6% YoY
Orthofix posted 1Q18 revenue of US $108.7MM, +5.8% vs. 1Q17.
Orthofix Gains FDA Clearance of G-Beam Fusion Beaming System
Orthofix received FDA 510(k) clearance to market the G-Beam™ Fusion Beaming system to treat ...
Public Orthopaedic Companies: 2017 Revenue and 2018 Sales Drivers
By Julie A. Vetalice The 20 companies tracked in Exhibits 1 and 2 collectively grew +3.0% in 2017 vs. 2016. Individually, you’ll notice some stellar performance in particular segments. (Our final estimates for 2017 orthopaedic industry revenue can be found in
Orthofix Enters Agreement to Acquire Spinal Kinetics
Orthofix entered into a definitive agreement to acquire Spinal Kinetics for US $45MM in cash plus up to
Orthofix Gains FDA and CE Mark Approvals for PhysioStim
Orthofix gained FDA premarket and CE Mark approval for next-gen PhysioStim™ bone growth stimulators, used as a n...
Orthofix Cervical-Stim Device Shown to Improve Fusion Rates
Studies show that use of pulsed electromagnetic field treatment after ACDF significantly increased the fusion rate vs. control at 6...
Orthofix Announces 4Q17, 2017 Revenue
Orthofix posted 4Q17 revenue of US $116.9MM, +7.7% from 4Q16, and 2017 revenue of $433.8MM, +5.9% vs. 2016....
Orthofix to Study PEMF in Rotator Cuff Repair
Orthofix commenced enrollment in a clinical trial of the RCStim™ pulsed electromagnetic field
Orthofix Gains FDA Clearance for FORZA XP Expandable Spacer
Orthofix received FDA 510(k) clearance to market the FORZA® XP Expandable Spacer for poster...
Orthofix Reports Preliminary 4Q17, 2017 Revenue
Orthofix reported preliminary 4Q17 revenue of US $116.9MM, +7.7% vs. 4Q16, and 2017 revenue of $433.8MM, +...
The Orthopaedic Products and Services of 2017
By Julie A. Vetalice The annual rundown of products and services is like attending a reunion—we’re looking back over the year and keeping you informed on what everyone is doing. Here’s what made headlines with market entry in 2017. We’ll start with services, and ...
OrthoPediatrics Posts 3Q17 YoY Growth of 22%
OrthoPediatrics posted 3Q17 revenue of US $12.4MM, +22.1% vs. 3Q16, and YTD revenue of $34.0MM, +22.2%
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2018 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group